
浏览全部资源
扫码关注微信
陆军军医大学军事预防医学系军队劳动卫生学教研室/教育部电磁辐射医学防护重点实验室,重庆 400038
皮会丰,E-mail:pihuifeng2010@163.com
纸质出版日期:2024-03-25,
收稿日期:2023-03-15,
扫 描 看 全 文
郝蓉蓉,李玲,田丽等.慢性镉暴露小鼠的肝脂质组学研究[J].局解手术学杂志,2024,33(03):194-199.
HAO Rong-rong,LI Ling,TIAN Li,et al.Hepatic lipidomics study in chronic cadmium-exposed mice[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2024,33(03):194-199.
郝蓉蓉,李玲,田丽等.慢性镉暴露小鼠的肝脂质组学研究[J].局解手术学杂志,2024,33(03):194-199. DOI: 10.11659/jjssx.03E023098.
HAO Rong-rong,LI Ling,TIAN Li,et al.Hepatic lipidomics study in chronic cadmium-exposed mice[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2024,33(03):194-199. DOI: 10.11659/jjssx.03E023098.
目的
2
研究慢性镉暴露小鼠肝脂质组学的改变,并筛选出具有显著差异的脂质亚类、脂质分子和富集的代谢通路。
方法
2
选用12只SPF级雄性C57BL/6J小鼠(8周龄),随机分成对照组(正常水喂养)和实验组[镉水(0.6 mg /L CdCl
2
)喂养],每组6只。在镉暴露6个月后处死小鼠,即刻摘取新鲜的肝组织。对肝组织行脂质油红O染色和脂质组学分析。
结果
2
与对照组相比,实验组小鼠肝组织脂质油红O染色未出现红色。通过脂质组学筛选到17种具有显著差异的脂质亚类,144个具有显著差异的脂质分子。将具有显著差异的脂质分子通过KEGG富集得到以下通路:甘油磷脂代谢、亚油酸代谢、α-亚麻酸代谢、糖基磷脂酰肌醇生物合成、甘油脂代谢、花生四烯酸代谢。
结论
2
本研究通过建立慢性镉暴露模型,揭示了慢性镉暴露会诱导小鼠肝中脂质亚类和脂质代谢物的紊乱,为了解慢性镉暴露导致的非酒精性脂肪性肝病提供依据。
Objective
2
To study the change of lipidomics in chronic cadmium-exposed mice,thereby screening out lipid subclasses,lipid molecules and enriched metabolic pathways with significant differences.
Methods
2
Twelve SPF male C57BL/6J mice (8 weeks old) were randomly divided into the control group (normal water feeding) and the experimental group [cadmium water (0.6 mg/L of CdCl
2
) feeding],with 6 mice in each group.Mice were sacrificed after 6 months of cadmium exposure,and fresh liver tissues were collected immediately.Lipid oil red O staining and lipidomics analysis were performed on liver tissue.
Results
2
Compared with the control group,the liver tissue of mice in the experimental group did not appear red after lipid oil red O staining.Seventeen lipid subclasses with significant differences and 144 lipid molecules with significant differences were screened out by lipidomics.These lipid molecules with significant differences were enriched in glycerophospholipid metabolism,linoleic acid metabolism,alpha-linolenic acid metabolism,glycosylphosphatidylinositol biosynthesis,glycerolipid metabolism and arachidonic acid metabolism by KEGG.
Conclusion
2
This study reveals that chronic cadmium exposure can induce the disorder of lipid subclasses and lipid metabolites in the liver of mice,which provides a basis for understanding the non-alcoholic fatty liver disease caused by chronic cadmium exposure.
慢性镉暴露肝脂质组学非酒精性脂肪性肝病
chronic cadmium exposureliverlipidomicsnon-alcoholic fatty liver disease
Clemens S.Toxic metal accumulation,responses to exposure and mechanisms of tolerance in plants[J].Biochimie,2006,88(11):1707-1719.doi:10.1016/j.biochi.2006.07.003http://dx.doi.org/10.1016/j.biochi.2006.07.003.
Souza-Arroyo V,Fabián JJ,Bucio-Ortiz L,et al.The mechanism of the cadmium-induced toxicity and cellular response in the liver[J].Toxicology,2022,480:153339.doi:10.1016/j.tox.2022.153339http://dx.doi.org/10.1016/j.tox.2022.153339.
Szántó M,Gupte R,Kraus W,et al.PARPs in lipid metabolism and related diseases[J].Prog Lipid Res,2021,84:101117.doi:10.1016/j.plipres.2021.101117http://dx.doi.org/10.1016/j.plipres.2021.101117.
Zhu Y,Zhao Y,Chai X,et al.Chronic exposure to low-dose cadmium facilitated nonalcoholic steatohepatitisin mice by suppressing fatty acid desaturation[J].Ecotoxicol Environ Saf,2022,233:113306.doi:10.1016/j.ecoenv.2022.113306http://dx.doi.org/10.1016/j.ecoenv.2022.113306.
He X,Gao J,Hou H,et al.Inhibition of mitochondrial fatty acid oxidation contributes to development of nonalcoholic fatty liver disease induced by environmental cadmium exposure[J].Environ Sci Technol,2019,53(23):13992-14000.doi:10.1021/acs.est.9b05131http://dx.doi.org/10.1021/acs.est.9b05131.
李自发,张浩,任萌,等.槲皮素对镉致小鼠肝脏脂质代谢紊乱模型的保护效应[J].实验动物与比较医学,2021,41(4):305-312.doi:10.12300/j.issn.1674-5817.2021.007http://dx.doi.org/10.12300/j.issn.1674-5817.2021.007.
殷艳.基于液相色谱-高分辨质谱技术的食品脂质组学分析[J].检验检疫学刊,2020,30(2):87-89.
Taguchi R,Ishikawa M.Precise and global identification of phospholipid molecular species by an Orbitrap mass spectrometer and automated search engine Lipid Search[J].J Chromatogr A,2010,1217(25):4229-4239.doi:10.1016/j.chroma.2010.04.034http://dx.doi.org/10.1016/j.chroma.2010.04.034.
Wang M,Chen Z,Song W,et al.A review on cadmium exposure in the population and intervention strategies against cadmium toxicity[J].Bull Environ Contam Toxicol,2021,106(1):65-74.doi:10.1007/s00128-020-03088-1http://dx.doi.org/10.1007/s00128-020-03088-1.
Hao R,Xiao H,Wang H,et al.Transcriptomics integrated with metabolomics unravels the interweaving of inflammatory response and 1-stearoyl-2-arachidonoyl-sn-glycerol metabolic disorder in chronic cadmium exposure-induced hepatotoxicity[J].Environ Toxicol Pharmacol,2023,101:104172.doi:10.1016/j.etap.2023.104172http://dx.doi.org/10.1016/j.etap.2023.104172.
罗燕,邓平,陈梦研,等.慢性镉暴露小鼠肝、肾、脑组织镉分布情况和肾毒性研究[J].局解手术学杂志,2022,31(5):373-378.doi:10.11659/jjssx.11E021135http://dx.doi.org/10.11659/jjssx.11E021135.
Zhang L,Wang H,Abel G,et al.The effects of gene-environment interactions between cadmium exposure and apolipoprotein E4 on memory in a mouse model of Alzheimer´s disease[J].Toxicol Sci,2020,173(1):189-201.doi:10.1093/toxsci/kfz218http://dx.doi.org/10.1093/toxsci/kfz218.
Go YM,Sutliff RL,Chandler JD,et al.Low-dose cadmium causes metabolic and genetic dysregulation associated with fatty liver disease in mice[J].Toxicol Sci,2015,147(2):524-534.doi:10.1093/toxsci/kfv149http://dx.doi.org/10.1093/toxsci/kfv149.
Mezynska M,Brzóska MM.Environmental exposure to cadmium:a risk for health of the general population in industrialized countries and preventive strategies[J].Environ Sci Pollut Res Int,2018,25(4):3211-3232.doi:10.1007/s11356-017-0827-zhttp://dx.doi.org/10.1007/s11356-017-0827-z.
Deng P,Li J,Lu Y,et al.Chronic cadmium exposure triggered ferroptosis by perturbing the STEAP3-mediated glutathione redox balance linked to altered metabolomic signatures in humans[J].Sci Total Environ,2023,905:167039.doi:10.1016/j.scitotenv.2023. 167039http://dx.doi.org/10.1016/j.scitotenv.2023.167039.
王爰民,刘丽华,刘汉俊.甘油三脂和胆固醇浓度对血浆粘度的影响[J].中国血液流变学杂志,1993(2):4-5.
Duran EK,Aday AW,Cook NR,et al.Triglyceride-rich lipoprotein cholesterol,small dense LDL cholesterol,and incident cardiovascular disease[J].J Am CollCardiol,2020,75(17):2122-2135.doi:10.1016/j.jacc.2020.02.059http://dx.doi.org/10.1016/j.jacc.2020.02.059.
Budoff M.Triglycerides and triglyceride-rich lipoproteins in the causal pathway of cardiovascular disease[J].Am J Cardiol,2016,118(1):138-145.doi:10.1016/j.amjcard.2016.04.004http://dx.doi.org/10.1016/j.amjcard.2016.04.004.
Alves-Bezerra M,Cohen DE.Triglyceride metabolism in the liver[J].Compr Physiol,2017,8(1):1-8.doi:10.1002/cphy.c170012http://dx.doi.org/10.1002/cphy.c170012.
毛逸霖,周俊,陈凯,等.甘油二酯的代谢机制及营养功能特性研究进展[J].中国油脂,2023,48(11):80-89.doi:10.19902/j.cnki.zgyz.1003-7969.220450http://dx.doi.org/10.19902/j.cnki.zgyz.1003-7969.220450.
Lyu K,Zhang Y,Zhang D,et al.A membrane-bound diacylglycerol species induces PKCϵ-mediated hepatic insulin resistance[J].Cell Metab,2020,32(4):654-664.e5.doi:10.1016/j.cmet.2020. 08.001http://dx.doi.org/10.1016/j.cmet.2020.08.001.
Ling J,Chaba T,Zhu L,et al.Hepatic ratio of phosphatidylcholine to phosphatidylethanolamine predicts survival after partial hepatectomy in mice[J].Hepatology,2012,55(4):1094-1102.doi:10.1002/hep.24782http://dx.doi.org/10.1002/hep.24782.
Li Z,Agellon LB,Allen TM,et al.The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis[J].Cell Metab,2006,3(5):321-331.doi:10.1016/j.cmet.2006.03.007http://dx.doi.org/10.1016/j.cmet.2006.03.007.
蒲云峰,张伟敏,钟 耕.神经酰胺功能和应用[J].粮食与油脂,2005(7):14-16.doi:10.3969/j.issn.1008-9578.2005.07.004http://dx.doi.org/10.3969/j.issn.1008-9578.2005.07.004.
Chaurasia B,Summers SA.Ceramides-lipotoxic inducers of metabolic disorders:(trends in endocrinology and metabolism 26,538-550; 2015)[J].Trends Endocrinol Metab,2018,29(1):66-67.doi:10.1016/j.tem.2017.09.005http://dx.doi.org/10.1016/j.tem.2017.09.005.
Choi RH,Tatum SM,Symons JD,et al.Ceramides and other sphingolipids as drivers of cardiovascular disease[J].Nat Rev Cardiol,2021,18(10):701-711.doi:10.1038/s41569-021-00536-1http://dx.doi.org/10.1038/s41569-021-00536-1.
Chaurasia B,Summers SA.Ceramides-lipotoxic inducers of metabolic disorders[J].Trends Endocrinol Metab,2015,26(10):538-550.doi:10.1016/j.tem.2015.07.006http://dx.doi.org/10.1016/j.tem.2015.07.006.
Xia JY,Holland WL,Kusminski C,et al.Targeted induction of ceramide degradation leads to improved systemic metabolism and reduced hepatic steatosis[J].Cell Meta,2015,22(2):266-278.doi:10.1016/j.cmet.2015.06.007http://dx.doi.org/10.1016/j.cmet.2015.06.007.
Paul B,Lewinska M,Andersen JB.Lipid alterations in chronic liver disease and liver cancer[J].JHEP Rep,2022,4(6):100479.doi:10.1016/j.jhepr.2022.100479http://dx.doi.org/10.1016/j.jhepr.2022.100479.
Naughton SS,Mathai ML,Hryciw D,et al.Linoleic acid and the pathogenesis of obesity[J].Prostaglandins Other Lipid Mediat,2016,125:90-99.doi:10.1016/j.prostaglandins.2016.06.003http://dx.doi.org/10.1016/j.prostaglandins.2016.06.003.
Maciejewska D,Drozd A,Skonieczna-Żydecka K,et al.Eicosanoids in nonalcoholic fatty liver disease (NAFLD) progression.Do serum eicosanoids profile correspond with liver eicosanoids content during NAFLD development and progression[J].Molecules,2020,25(9):2026.doi:10.3390/molecules25092026http://dx.doi.org/10.3390/molecules25092026.
Sonnweber T,Pizzini A,Nairz M,et al.Arachidonic acid metabolites in cardiovascular and metabolic diseases[J].Int J Mol Sci,2018,19(11):3285.doi:10.3390/ijms19113285http://dx.doi.org/10.3390/ijms19113285.
Prentki M,Madiraju SR.Glycerolipid metabolism and signaling in health and disease[J].Endocr Rev,2008,29(6):647-676.doi:10.1210/er.2008-0007http://dx.doi.org/10.1210/er.2008-0007.
0
浏览量
1
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621